Steris (STE) Change in Accured Expenses (2018 - 2026)
Steris' (STE) quarterly Change in Accured Expenses came in at $74.3 million in Q1 2026, up 71.2% year-on-year from $43.4 million in Q1 2025, and up 190.23% quarter-over-quarter from $25.6 million in Q4 2025.
Steris (STE) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Steris' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at $74.3 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 71.2% year-over-year to $74.3 million in Q1 2026; TTM through Mar 2026 was $47.8 million, a 22.88% increase from a year earlier, with the FY2026 full-year figure at $47.8 million, up 22.88% from the prior year.
- Change in Accured Expenses improved to $74.3 million in Q1 2026 per STE's latest filing, from $25.6 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $74.3 million in Q1 2026 and bottomed at -$85.9 million in Q3 2022.
- The 5-year median for Change in Accured Expenses is $18.2 million (2024), against an average of $6.2 million.
- Across the five-year window, Change in Accured Expenses plunged 1344.01% in 2022 and jumped 3410.02% in 2023, its largest moves.
- Year by year, Change in Accured Expenses stood at $46.0 million in 2022, then increased by 2.63% to $47.2 million in 2023, then slumped by 34.74% to $30.8 million in 2024, then fell by 16.88% to $25.6 million in 2025, then surged by 190.23% to $74.3 million in 2026.
- Per Business Quant, the three latest STE Change in Accured Expenses figures stand at $74.3 million (Q1 2026), $25.6 million (Q4 2025), and -$42.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 74.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.30 Mn |
| Mar 31, 2026 | 74.30 Mn |
| Dec 31, 2025 | 25.60 Mn |
| Dec 31, 2025 | 25.60 Mn |
| Sep 30, 2025 | -42.90 Mn |
| Sep 30, 2025 | -42.90 Mn |
| Jun 30, 2025 | -9.20 Mn |
| Jun 30, 2025 | -9.20 Mn |
| Mar 31, 2025 | 43.40 Mn |
| Mar 31, 2025 | 43.40 Mn |
| Dec 31, 2024 | 30.80 Mn |
| Dec 31, 2024 | 30.80 Mn |
| Sep 30, 2024 | -36.80 Mn |
| Sep 30, 2024 | -36.80 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 18.25 Mn |
| Mar 31, 2024 | 18.25 Mn |
| Dec 31, 2023 | 47.20 Mn |
| Dec 31, 2023 | 47.20 Mn |